Dynavax Technologies Corporation (DVAX) - NASDAQ
Company Description
Dynavax Technologies Corp. is a clinical-stage biopharmaceutical company that uses toll-like receptor TLR biology to discover and develop novel vaccines and therapeutics. The company's development programs are organized under its three areas of focus: vaccine adjuvants, cancer immunotherapy, and... More
Sector: Healthcare
Industry: Drug Manufacturers - Other
Country: United States